Passage Bio Stock Quote PASG - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Passage Bio Inc (PASG) Quote

Passage Bio Inc (PASG)

1.19

0.06

(5.31%)

Closed May 28 4:00PM

Delayed by 15 minutes

1.17

-0.02

(-1.68%)

After Hours: 7:59PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

1.19

Bid

1.17

Ask

1.35

Volume

66,226

1.02 Day's Range 1.18

0.5751 52 Week Range 1.79

Market Cap

Previous Close

1.13

Open

1.13

Last Trade

Last Trade Time

Financial Volume

$ 73,515

VWAP

1.1101

Average Volume (3m)

295,582

Shares Outstanding

55,598,796

Dividend Yield

-

PE Ratio

-0.64

Earnings Per Share (EPS)

-1.84

Revenue

-

Net Profit

-102.06M

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.passagebio.com/home/default.aspx

Headquarters

Wilmington, Delaware, USA

Founded

1970

Passage Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PASG. The last closing price for Passage Bio was $1.13. Over the last year, Passage Bio shares have traded in a share price range of $ 0.5751 to $ 1.79.

Passage Bio currently has 55,598,796 shares outstanding. The market capitalization of Passage Bio is $65.05 million. Passage Bio has a price to earnings ratio (PE ratio) of -0.64.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award

PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

Updated interim data from the upliFT-D trial in FTD-GRN demonstrated that Dose 1 PBFT02 achieved consistent elevation of CSF progranulin at six months post-treatment in the two patients with...

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-6.29921259843	1.27	1.3	1.02	326619	1.14747768	CS
4	-0.12	-9.16030534351	1.31	1.64	1.02	164857	1.29861348	CS
12	-0.42	-26.0869565217	1.61	1.79	1.02	295582	1.38800111	CS
26	0.5449	84.4675244148	0.6451	1.79	0.6	472241	1.07033077	CS
52	0.14	13.3333333333	1.05	1.79	0.5751	358794	0.97606476	CS
156	-13.025	-91.6285613788	14.215	16.14	0.5751	325177	3.60670817	CS
260	-21.08	-94.6564885496	22.27	38.23	0.5751	312992	8.02253399	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STSSSharps Technology Inc	$ 0.5289 (146.80%)	302.07M
AWINAERWINS Technologies Inc	$ 8.99 (139.10%)	5.41M
INSMInsmed Inc	$ 48.107 (118.67%)	33.41M
GVVisionary Holdings Inc	$ 0.38 (90.00%)	10.33M
SOBRSOBR Safe Inc	$ 0.41 (82.22%)	130.83M
APDNApplied DNA Sciences Inc	$ 0.580601 (-70.82%)	9.45M
LUCYInnovative Eyewear Inc	$ 0.40 (-59.31%)	84.98M
MRAIMarpai Inc	$ 0.90 (-53.61%)	803.83k
TOIIWOncology Institute Inc	$ 0.021 (-52.60%)	293.22k
SHOTWSafety Shot Inc	$ 0.21 (-36.07%)	24.26k
PEGYPineapple Energy Inc	$ 0.2595 (45.70%)	676.58M
GWAVGreenwave Technology Solutions Inc	$ 0.0782 (-7.89%)	306.52M
STSSSharps Technology Inc	$ 0.5289 (146.80%)	302.07M
CRKNCrown Electrokinetics Corporation	$ 0.1073 (6.24%)	232.53M
OBLGOblong Inc	$ 0.21 (19.32%)	146.15M

Monksdream

Monksdream 2 days ago

Monksdream

Monksdream 3 weeks ago

Sirpeter

Sirpeter 2 months ago

Running... boom!!!

Monksdream

Monksdream 2 months ago

glenn1919

glenn1919 2 months ago

PASG..........................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 3 months ago

PASG new 52 week high

TrendTrade2016

TrendTrade2016 3 months ago

PASG setting up nicely. Another beautiful call by the only true chartist around

Sirpeter

Sirpeter 3 months ago

TrendTrade2016

TrendTrade2016 3 months ago

PASG...NEXT CRDL

glenn1919

glenn1919 3 months ago

PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3 months ago

PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 3 months ago

turning stone

turning stone 4 months ago

As a new investor in PASG, I am looking forward to another high roller in the next number of years. I bought ARNA years ago at 1.90 and rode it out to $99/share when they were bought out by Phizer Pharm. I would like to have my 5 grandkids share the spoils on this one. With a multi-pipe line, a couple should make it to the end of the line with FDA approval. At the number of shares I purchased multiple times I can afford to run for the hills if a sudden disaster should hit this one. This company is 21 miles from my home and I will stop by shortly and have a sit down with their home-based PR. person. Good luck to all. You may also want to look at BLRX {BIO-Line Inc }

Walter4

Walter4 5 months ago

Data readout should be incoming shortly

Monksdream

Monksdream 9 months ago

PASG new 52 week low

catinhat

catinhat 2 years ago

So...anybody out there? Thoughts on upcoming abstract, etc?

Recent long.

dealerschool2006

dealerschool2006 3 years ago

PASG down from panic selling due to the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $22.00 per share.

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions